105 related articles for article (PubMed ID: 12429526)
21. Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.
Wexler-Cohen Y; Ashkenazi A; Viard M; Blumenthal R; Shai Y
FASEB J; 2010 Nov; 24(11):4196-202. PubMed ID: 20605950
[TBL] [Abstract][Full Text] [Related]
22. Multimerized CHR-derived peptides as HIV-1 fusion inhibitors.
Nomura W; Hashimoto C; Suzuki T; Ohashi N; Fujino M; Murakami T; Yamamoto N; Tamamura H
Bioorg Med Chem; 2013 Aug; 21(15):4452-8. PubMed ID: 23800723
[TBL] [Abstract][Full Text] [Related]
23. The conserved residue Arg46 in the N-terminal heptad repeat domain of HIV-1 gp41 is critical for viral fusion and entry.
Wang X; Xiong W; Ma X; Wei M; Chen Y; Lu L; Debnath AK; Jiang S; Pan C
PLoS One; 2012; 7(9):e44874. PubMed ID: 22970321
[TBL] [Abstract][Full Text] [Related]
24. Trimeric heptad repeat synthetic peptides HR1 and HR2 efficiently inhibit HIV-1 entry.
Mzoughi O; Teixido M; Planès R; Serrero M; Hamimed I; Zurita E; Moreno M; Granados G; Lakhdar-Ghazal F; BenMohamed L; Giralt E; Bahraoui E
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31477581
[TBL] [Abstract][Full Text] [Related]
25. Synergistic inhibition of HIV-1 envelope-mediated membrane fusion by inhibitors targeting the N and C-terminal heptad repeats of gp41.
Gustchina E; Louis JM; Bewley CA; Clore GM
J Mol Biol; 2006 Dec; 364(3):283-9. PubMed ID: 17010381
[TBL] [Abstract][Full Text] [Related]
26. Covalent fusion inhibitors targeting HIV-1 gp41 deep pocket.
Bai Y; Xue H; Wang K; Cai L; Qiu J; Bi S; Lai L; Cheng M; Liu S; Liu K
Amino Acids; 2013 Feb; 44(2):701-13. PubMed ID: 22961335
[TBL] [Abstract][Full Text] [Related]
27. Helical interactions in the HIV-1 gp41 core reveal structural basis for the inhibitory activity of gp41 peptides.
Shu W; Liu J; Ji H; Radigen L; Jiang S; Lu M
Biochemistry; 2000 Feb; 39(7):1634-42. PubMed ID: 10677212
[TBL] [Abstract][Full Text] [Related]
28. Multimerized HIV-gp41-derived peptides as fusion inhibitors and vaccines.
Nomura W; Mizuguchi T; Tamamura H
Biopolymers; 2016 Nov; 106(4):622-8. PubMed ID: 26583370
[TBL] [Abstract][Full Text] [Related]
29. Electrostatically constrained alpha-helical peptide inhibits replication of HIV-1 resistant to enfuvirtide.
Nishikawa H; Nakamura S; Kodama E; Ito S; Kajiwara K; Izumi K; Sakagami Y; Oishi S; Ohkubo T; Kobayashi Y; Otaka A; Fujii N; Matsuoka M
Int J Biochem Cell Biol; 2009 Apr; 41(4):891-9. PubMed ID: 18834950
[TBL] [Abstract][Full Text] [Related]
30. Role of the ectodomain of the gp41 transmembrane envelope protein of human immunodeficiency virus type 1 in late steps of the membrane fusion process.
Bär S; Alizon M
J Virol; 2004 Jan; 78(2):811-20. PubMed ID: 14694113
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformation.
Kliger Y; Shai Y
J Mol Biol; 2000 Jan; 295(2):163-8. PubMed ID: 10623516
[TBL] [Abstract][Full Text] [Related]
32. Identification of the HIV-1 gp41 core-binding motif--HXXNPF.
Huang JH; Liu ZQ; Liu S; Jiang S; Chen YH
FEBS Lett; 2006 Sep; 580(20):4807-14. PubMed ID: 16904109
[TBL] [Abstract][Full Text] [Related]
33. Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivation.
Dimitrov AS; Louis JM; Bewley CA; Clore GM; Blumenthal R
Biochemistry; 2005 Sep; 44(37):12471-9. PubMed ID: 16156659
[TBL] [Abstract][Full Text] [Related]
34. Addition of artificial salt bridge by Ile646Lys mutation in gp41 coiled-coil domain regulates 6-helical bundle formation.
Zhao L; Hu ZW; Tong P; Chen YX; Zhao YF; Li YM
Bioorg Med Chem Lett; 2013 May; 23(9):2727-32. PubMed ID: 23522564
[TBL] [Abstract][Full Text] [Related]
35. The hydrophobic pocket contributes to the structural stability of the N-terminal coiled coil of HIV gp41 but is not required for six-helix bundle formation.
Dwyer JJ; Hasan A; Wilson KL; White JM; Matthews TJ; Delmedico MK
Biochemistry; 2003 May; 42(17):4945-53. PubMed ID: 12718536
[TBL] [Abstract][Full Text] [Related]
36. Interhelical interactions in the gp41 core: implications for activation of HIV-1 membrane fusion.
Wang S; York J; Shu W; Stoller MO; Nunberg JH; Lu M
Biochemistry; 2002 Jun; 41(23):7283-92. PubMed ID: 12044159
[TBL] [Abstract][Full Text] [Related]
37. Different susceptibility of human immunodeficiency virus type 1 to Env gp41-derived synthetic peptides corresponding to the C-terminal heptad repeat region.
N A PI; Li GM; Warachit J; Iwabu Y; Tsuji S; Auwanit W; Yamamoto D; Goto T; Hayashi Y; Kiso Y; Ikuta K
Microbes Infect; 2005 Mar; 7(3):356-64. PubMed ID: 15780966
[TBL] [Abstract][Full Text] [Related]
38. Interactions between HIV-1 gp41 core and detergents and their implications for membrane fusion.
Shu W; Ji H; Lu M
J Biol Chem; 2000 Jan; 275(3):1839-45. PubMed ID: 10636883
[TBL] [Abstract][Full Text] [Related]
39. Cell-cell and virus-cell fusion assay-based analyses of alanine insertion mutants in the distal α9 portion of the JRFL gp41 subunit from HIV-1.
Yamamoto M; Du Q; Song J; Wang H; Watanabe A; Tanaka Y; Kawaguchi Y; Inoue JI; Matsuda Z
J Biol Chem; 2019 Apr; 294(14):5677-5687. PubMed ID: 30737278
[TBL] [Abstract][Full Text] [Related]
40. Hydrophobic mutations in buried polar residues enhance HIV-1 gp41 N-terminal heptad repeat-C-terminal heptad repeat interactions and C-peptides' anti-HIV activity.
Zheng B; Wang K; Lu L; Yu F; Cheng M; Jiang S; Liu K; Cai L
AIDS; 2014 Jun; 28(9):1251-60. PubMed ID: 24625369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
